William Blair Issues Negative Forecast for Danaher Earnings

Danaher Co. (NYSE:DHR) – Equities research analysts at William Blair lowered their Q3 2025 earnings estimates for shares of Danaher in a report released on Tuesday, April 22nd. William Blair analyst M. Larew now anticipates that the conglomerate will post earnings per share of $1.88 for the quarter, down from their prior estimate of $1.94. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. William Blair also issued estimates for Danaher’s Q4 2025 earnings at $2.26 EPS, FY2025 earnings at $7.67 EPS and Q1 2026 earnings at $2.10 EPS.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%.

Other equities research analysts also recently issued reports about the stock. Jefferies Financial Group cut their target price on shares of Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research report on Tuesday. Barclays lifted their price target on shares of Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a report on Tuesday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday. Wells Fargo & Company reduced their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Finally, Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective on the stock in a research note on Friday, March 14th. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $264.40.

Danaher Stock Performance

Shares of DHR stock opened at $197.37 on Friday. The firm has a market capitalization of $141.06 billion, a price-to-earnings ratio of 37.38, a PEG ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business’s 50-day moving average price is $200.87 and its 200-day moving average price is $224.58. Danaher has a 12 month low of $171.00 and a 12 month high of $281.70.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were issued a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date was Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher’s dividend payout ratio is presently 24.85%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 11.10% of the company’s stock.

Hedge Funds Weigh In On Danaher

Hedge funds have recently bought and sold shares of the company. Norges Bank purchased a new position in Danaher during the fourth quarter worth about $2,130,740,000. GAMMA Investing LLC grew its holdings in shares of Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate’s stock valued at $383,524,000 after acquiring an additional 1,863,381 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Danaher in the fourth quarter valued at approximately $391,172,000. Two Sigma Advisers LP increased its position in shares of Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate’s stock valued at $376,347,000 after acquiring an additional 1,601,800 shares during the last quarter. Finally, Capital World Investors boosted its position in Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock worth $1,460,215,000 after purchasing an additional 1,566,658 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.